Minerva Imaging are proud to partner with Targeted Radiopharmaceutical (TPR) Summit, June 11-13, 2019, Munich, Germany.
Short about Minerva:
Minerva Imaging is a scientifically driven CRO. We have substantial experience working with targeted radionuclide therapy. Studies can be designed utilizing our catalogue of PDX or cell line derived models established subcutaneously or orthotopically and combined with non-invasive in vivo PET or SPECT imaging.
Our competences build on more than two decades of research within oncology and molecular imaging at the University of Copenhagen and Rigshospitalet, the National University Hospital of Denmark.
Please feel free to reach out to take advantage of the 20% discount on passes to the summit and schedule a meeting, by completing the below contact form.